Drugs / TMC558445
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00838760 | Feb → Oct 2009 | — | Tibotec Pharmaceuticals, Ireland | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TMC558445 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00838760 ↗ |
| Route | Oral | “increasing single oral doses of TMC558445” NCT00838760 ↗ |